OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for July, 2016

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2016-07-31 00:15 Can Sanofi Increased Hunger for Medivation Drive Out Competition? and more... 2016-07-30 00:15 Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions? and more... 2016-07-29 12:15 How Novartis Animal Health Factored into Eli Lilly’s 2Q Earnings and more... 2016-07-29 00:15 Megamerger-happy investors bid up AZ shares on speculation that Novartis might try a takeover and more... 2016-07-28 12:15 Boston Scientific buys pain-management business, boosts its outlook and more... 2016-07-28 00:15 Abbott CEO Spends $45.5 Million to Boost Personal Stock Holdings and more... 2016-07-27 12:15 Lilly CEO John Lechleiter to retire by year-end and more... 2016-07-27 00:15 FDA enhances warnings on group of strong antibiotics and more... 2016-07-26 12:15 Lilly sales beat estimates, helped by newer drugs and more... 2016-07-26 00:15 Bristol-Myers Squibb Co (BMY) Q2 Earnings: What To Expect and more... 2016-07-25 12:15 Did Abbott rep in India kill himself over sales goals? and more... 2016-07-23 12:15 Amgen, Inc. 2Q Earnings: Here’s What To Expect and more... 2016-07-22 12:15 Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai and more... 2016-07-22 00:15 More Than 400 Women Are Now Suing Merck for Unequal Pay and more... 2016-07-21 12:15 Biogen CEO George Scangos to step down and more... 2016-07-20 12:15 Abbott sales beat on higher demand for medical devices and more... 2016-07-20 00:15 Bristol-Myers settles for $30 million over California kickback claims and more... 2016-07-19 12:15 U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta and more... 2016-07-18 12:15 Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application and more... 2016-07-17 12:15 Will Perrigo be Gobbled Up In Consumer Health Consolidation? 2016-07-17 00:15 3 Big-Cap Drugmakers Reporting Earnings Next Week and more... 2016-07-15 12:15 Survey: Medical device tax suspension boosts jobs, innovation and more... 2016-07-15 00:15 Martin Shkreli will have his day(s) in court – next June and more... 2016-07-14 12:15 Should You Blow the Whistle? and more... 2016-07-14 00:15 Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales and more... 2016-07-13 12:15 Juno Therapeutics (JUNO) Stock Surges After FDA Lifts Clinical Hold and more... 2016-07-13 00:15 FDA Panel Resoundingly Backs Amgen's Biosimilar Humira and more... 2016-07-12 12:15 Shire Secures Access to 16 Million-Strong US Dry Eye Disease Market With New Drug Approval and more... 2016-07-11 12:15 AstraZeneca considering $10-billion offer for Medivation: report and more... 2016-07-11 00:15 FDA's advisers on opioids booted for ties to industry, AP learns and more... 2016-07-10 12:15 Here's How Pfizer's Protecting Its Kidney Cancer Drug From New Competitors 2016-07-09 12:15 In Juno patient deaths, echoes seen of earlier failed company and more... 2016-07-08 12:15 Elizabeth Holmes Has Been Banned. What Does That Mean For Theranos? and more... 2016-07-08 00:15 GSK enters Zika vax race, hot on Sanofi's heels and more... 2016-07-07 12:15 Why Valeant Pharmaceuticals Soared 15% Wednesday and more... 2016-07-07 00:15 Gilead Sciences: ‘This Could Be One of the Strongest Quarters in Some Time’ and more... 2016-07-06 12:15 In clinical trials, for-profit review boards are taking over for hospitals. Should they? and more... 2016-07-06 00:15 An Auction Process Could Be on Medivation's Horizon and more... 2016-07-05 12:15 Bristol-Myers buys Swedish company with immunotherapy treatment and more... 2016-07-03 00:15 J&amp;J's Janssen hit with $70 mln verdict in Risperdal trial and more... 2016-07-02 00:15 AstraZeneca sells off dermatology drug rights to LEO Pharma and more... 2016-07-01 12:15 Drug and device makers paid $6.5 billion to docs and teaching hospitals last year and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe